{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-120650","form_type":"8-K","ticker":"SENS","cik":"0001616543","company_name":"Senseonics Holdings, Inc.","filed_at":"2024-11-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.994670+00:00","generated_at":"2026-05-29T22:30:01.073224+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"medium","headline":"Senseonics updates corporate presentation at Stifel Healthcare Conference","bullets":["Presentation highlights Eversense 365 CGM system FDA clearance and commercial launch.","Collaboration with Mercy Health targeting up to 30,000 patients initiated Q3 2024, expansion expected 2025.","Gemini (self-powered) and Freedom (no transmitter) development programs progressing with IDE filing planned 2025.","CGM market opportunity described as $20B+ US TAM with ~21% CAGR."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-120650","json":"https://secwatch.observer/filing/0001104659-24-120650.json","markdown":"https://secwatch.observer/filing/0001104659-24-120650.md","text":"https://secwatch.observer/filing/0001104659-24-120650.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1616543/000110465924120650/0001104659-24-120650-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1616543/000110465924120650/tm2428905d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T22:30:01.073224+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}